ES2143181T3 - Derivados biciclicos de isotiourea utiles en terapia. - Google Patents

Derivados biciclicos de isotiourea utiles en terapia.

Info

Publication number
ES2143181T3
ES2143181T3 ES96903295T ES96903295T ES2143181T3 ES 2143181 T3 ES2143181 T3 ES 2143181T3 ES 96903295 T ES96903295 T ES 96903295T ES 96903295 T ES96903295 T ES 96903295T ES 2143181 T3 ES2143181 T3 ES 2143181T3
Authority
ES
Spain
Prior art keywords
useful
isotiourea
therapy
sub
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96903295T
Other languages
English (en)
Inventor
James Edwin Macdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502669.6A external-priority patent/GB9502669D0/en
Priority claimed from GBGB9502670.4A external-priority patent/GB9502670D0/en
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2143181T3 publication Critical patent/ES2143181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PROPONEN NUEVOS COMPUESTOS DE FORMULA (I) DONDE D REPRESENTA UN GRUPO ALQUILO DE 1 A 6 CARBONOS; T REPRESENTA UNA CADENA DE ALQUILENO SATURADA O INSATURADA DE C{SUB,3-5} SUSTITUIDA POR (CH{SUB,2}){SUB,M} SUSTITUIDO POR UB,A} NEN EN LA ESPECIFICACION JUNTO CON LOS PROCESOS PARA SU PREPARACION, LAS COMPOSICIONES QUE LOS CONTIENEN Y SU USO EN TERAPEUTICA. SE PREVE QUE LOS COMPUESTOS DE FORMULA (I) SEAN UTILES, ENTRE OTRAS COSAS, EN EL TRATAMIENTO DE TRASTORNOS NEURODEGENERATIVOS.
ES96903295T 1995-02-11 1996-02-09 Derivados biciclicos de isotiourea utiles en terapia. Expired - Lifetime ES2143181T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502669.6A GB9502669D0 (en) 1995-02-11 1995-02-11 Pharmaceutically active compounds
GBGB9502670.4A GB9502670D0 (en) 1995-02-11 1995-02-11 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
ES2143181T3 true ES2143181T3 (es) 2000-05-01

Family

ID=26306479

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96903295T Expired - Lifetime ES2143181T3 (es) 1995-02-11 1996-02-09 Derivados biciclicos de isotiourea utiles en terapia.

Country Status (29)

Country Link
US (2) US5786364A (es)
EP (1) EP0808307B1 (es)
JP (1) JPH10513194A (es)
KR (1) KR19980702114A (es)
CN (1) CN1181070A (es)
AR (1) AR002961A1 (es)
AT (1) ATE188689T1 (es)
AU (1) AU699546B2 (es)
BR (1) BR9607264A (es)
CA (1) CA2211299A1 (es)
CZ (1) CZ237597A3 (es)
DE (1) DE69606165T2 (es)
DK (1) DK0808307T3 (es)
EE (1) EE03439B1 (es)
ES (1) ES2143181T3 (es)
FI (1) FI973273A0 (es)
GR (1) GR3033135T3 (es)
HU (1) HUP9801363A3 (es)
IL (1) IL116966A (es)
IS (1) IS4528A (es)
NO (1) NO309036B1 (es)
NZ (1) NZ301831A (es)
PL (1) PL321741A1 (es)
PT (1) PT808307E (es)
RU (1) RU2157802C2 (es)
SK (1) SK281205B6 (es)
TR (1) TR199700769T1 (es)
TW (1) TW397812B (es)
WO (1) WO1996024588A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy
US6140322A (en) * 1995-11-07 2000-10-31 Astra Aktiebolag Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
TW458978B (en) * 1995-11-07 2001-10-11 Astra Ab Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
WO1998016526A1 (en) * 1996-10-16 1998-04-23 Glaxo Group Limited Tetrahydro-6h-pyrazino[1,2-b]isoquinoline 1,4-diones as apoprotein b-100 inhibitors
US5929085A (en) * 1996-11-06 1999-07-27 Astra Aktiebolag Amidine and isothiourea derivatives, compositions containing them and their use as inhibitors of nitric oxide synthase
SE9701681D0 (sv) 1997-05-05 1997-05-05 Astra Ab New compounds
GB9719530D0 (en) * 1997-09-12 1997-11-19 Smithkline Beecham Plc Novel compounds
DE19844291A1 (de) * 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
US6664293B2 (en) 1999-02-26 2003-12-16 Fujiwawa Pharmaceutical Co., Ltd. Amide compounds for the potentiation of cholinergic activity
GB0016169D0 (en) * 2000-06-30 2000-08-23 Univ London Diagnostic method
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
RU2223952C2 (ru) * 2001-06-04 2004-02-20 Институт физиологически активных веществ РАН Производные n,s-замещенных n'-1-[(гетеро)арил]-n'-[(гетеро)арил]метилизотиомочевин или их солей с фармакологически приемлемыми кислотами нх, способы получения их солей и оснований, фармацевтическая композиция, способ лечения и способ изучения глутаматэргической системы
RU2252936C2 (ru) * 2002-12-05 2005-05-27 Институт физиологически активных веществ РАН S-замещенные n-1-[(гетеро)арил]алкил-n`-[(гетеро)арил]алкилизотиомочевины, способ их получения, фармацевтическая композиция, способ изучения глутаматэргической системы, способы лечения (варианты)
ITTO20040125A1 (it) 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1157626B (de) * 1959-06-27 1963-11-21 Hoechst Ag Verfahren zur Herstellung von N-p-Alkoxy-phenyl-N'-chinolylthioharnstoffen mit tuberkulostatischen Eigenschaften
GB1178242A (en) * 1966-02-05 1970-01-21 Wellcome Found Novel Biologically Active Bis-Isothioureas
BE792078A (fr) * 1971-12-01 1973-05-29 Wander Ag Dr A Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
US4211867A (en) * 1976-03-19 1980-07-08 Mcneil Laboratories, Incorporated Nitrogen heterocyclic carboximidamide compounds
NL7902993A (nl) * 1978-04-24 1979-10-26 Rhone Poulenc Ind Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
GB8908063D0 (en) * 1989-04-11 1989-05-24 Beecham Group Plc Novel compounds
US4988688A (en) * 1989-08-02 1991-01-29 Warner-Lambert Company 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
AU5533094A (en) * 1992-11-27 1994-06-22 Wellcome Foundation Limited, The Enzyme inhibitors
EP0713483B1 (en) * 1993-08-12 2003-01-15 AstraZeneca AB Amidine derivatives with nitric oxide synthetase activities
EP0723438A1 (en) * 1993-10-04 1996-07-31 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy

Also Published As

Publication number Publication date
WO1996024588A1 (en) 1996-08-15
CA2211299A1 (en) 1996-08-15
HUP9801363A2 (hu) 1998-09-28
PT808307E (pt) 2000-04-28
DE69606165T2 (de) 2000-08-24
EP0808307A1 (en) 1997-11-26
NO309036B1 (no) 2000-12-04
TR199700769T1 (xx) 1998-03-21
IS4528A (is) 1997-07-21
IL116966A (en) 2000-02-17
CZ237597A3 (cs) 1998-05-13
EP0808307B1 (en) 2000-01-12
BR9607264A (pt) 1997-12-30
DE69606165D1 (de) 2000-02-17
TW397812B (en) 2000-07-11
EE9700168A (et) 1998-02-16
DK0808307T3 (da) 2000-05-08
SK104097A3 (en) 1998-10-07
NO973614L (no) 1997-09-29
MX9705965A (es) 1997-11-29
CN1181070A (zh) 1998-05-06
AU699546B2 (en) 1998-12-03
KR19980702114A (ko) 1998-07-15
AU4734796A (en) 1996-08-27
HUP9801363A3 (en) 1999-01-28
SK281205B6 (sk) 2001-01-18
US6040314A (en) 2000-03-21
EE03439B1 (et) 2001-06-15
NO973614D0 (no) 1997-08-05
NZ301831A (en) 1998-05-27
FI973273A (fi) 1997-08-08
FI973273A0 (fi) 1997-08-08
IL116966A0 (en) 1996-05-14
AR002961A1 (es) 1998-05-27
ATE188689T1 (de) 2000-01-15
RU2157802C2 (ru) 2000-10-20
GR3033135T3 (en) 2000-08-31
PL321741A1 (en) 1997-12-22
JPH10513194A (ja) 1998-12-15
US5786364A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
ES2143181T3 (es) Derivados biciclicos de isotiourea utiles en terapia.
AR009357A1 (es) Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa
ECSP034660A (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
ES2145922T3 (es) Compuestos espiro-azabiciclicos utiles en terapia.
AR003220A1 (es) Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento.
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
ES2124062T3 (es) Derivados de nucleosido fosforotioato, sintesis y uso de los mismos.
MX9302906A (es) Derivados de mercaptoacetilamida novedosos utiles como inhibidores de la encefalinasa.
KR870006891A (ko) 구강 위생 조성물
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
DK0668933T3 (da) Anvendelse af methioninase som antitumormiddel i antimethioninkemoterapi
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
MX9305947A (es) Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2165015T3 (es) 1,2-bis-aductos de nitroxidos estables con etilenos sustituidos y composiciones estabilizadas.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
DE3873007D1 (de) Kathartica.
ES2117474T3 (es) Derivados n-sustituidos del 4-hidroxiindol y composiciones de tinte de fibras queratinicas que los contienen.
ES2070416T3 (es) Moluscicidas.
ES2187070T3 (es) Composiciones de laca para el cabello autofobas.
MX9304820A (es) Derivados de 1, 4-benzodioxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2055026T3 (es) Derivados de cicloalcanoles sustituidos con azol, un procedimiento para producirlos y un uso de los derivados como un fungicida agricola y horticola.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
AR025351A1 (es) Agonistas retinoides selectivos par
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 808307

Country of ref document: ES